Dedicare (DEDI) Q3 2026 earnings summary

Executive summary

• Q3 net sales rose 31.2% YoY to SEK 511.7m; EBITA increased to SEK 30.9m from SEK 13.9m, led mainly by acquired Danish social care operations.

• Organic sales grew 2.1% in Q3 and 1.9% in Jan–Sep; organic earnings were in line with Q3 2025, while acquired operations drove most of the earnings improvement.

Financial highlights

• Q3 EBIT was SEK 28.8m (SEK 11.7m); profit after financial items SEK 25.3m (SEK 11.7m); net profit SEK 19.5m (SEK 9.6m).

• Q3 basic and diluted EPS were SEK 2.01 (SEK 1.01); Jan–Sep EPS was SEK 4.23 (SEK 2.68).

• Jan–Sep net sales increased 15.5% to SEK 1,261.9m; EBITA was SEK 59.7m (SEK 37.4m) and net profit SEK 40.9m (SEK 25.6m).

• Q3 operating cash flow was SEK 45.8m (SEK 2.0m); Jan–Sep operating cash flow was SEK 8.8m (SEK 8.1m).

Outlook and guidance

• Long-term growth objective is at least 10% yearly, including acquisitions; Q3 growth was 31.2%.

• Long-term EBITA margin target is 6.0%; Q3 margin reached 6.0%, while adjusted margin was 6.7%.

• Market conditions remained challenging in several business areas; priorities include efficiency and stronger underlying profitability.